Eléments de l'association

	Female	122
	Young Adult	20
	Female *Sauf* Young Adult"	106
	Young Adult *Sauf* Female"	4
	Female Et Young Adult	16
	Female Ou Young Adult	126
	*Corpus*	4660

List of bibliographic references

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000166	Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik Peiris	Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000274	Gerardo Chowell ; Lone Simonsen ; Rodrigo Fuentes ; Jose Flores ; Mark A. Miller ; Cécile Viboud	Severe mortality impact of the 1957 influenza pandemic in Chile
000369	Laurent Filleul ; Dany Bakoly Ranoaritiana ; Elsa Balleydier ; David Vandroux ; Clémence Ferlay ; Marie-Christine Jaffar-Bandjee ; Julien Jaubert ; Bénédicte Roquebert ; Bruno Lina [France] ; Martine Valette ; Bruno Hubert ; Sophie Larrieu ; Elise Brottet	A major impact of the influenza seasonal epidemic on intensive care units, Réunion, April to August 2016
000421	April J. Cobos [États-Unis] ; Clinton G. Nelson [États-Unis] ; Megan Jehn [États-Unis] ; Cécile Viboud [États-Unis] ; Gerardo Chowell [États-Unis]	Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona
000522	Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]	Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000561	Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]	H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
000563	Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]	Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
000602	Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]	A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000691	Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]	Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000859	Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis]	Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis
000A04	Tom Reichert [États-Unis] ; Gerardo Chowell [États-Unis] ; Jonathan A. Mccullers [États-Unis]	The age distribution of mortality due to influenza: pandemic and peri-pandemic
000A85	Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao	An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000D63	Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]	Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000D93	N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov	[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E74	N. Ikonen [Finlande] ; M. Strengell ; L. Kinnunen ; P. Osterlund ; J. Pirhonen ; M. Broman ; I. Davidkin ; T. Ziegler ; I. Julkunen	High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.
001132	Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao	A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021